Advisor Group Holdings, Inc.

SEC CIK: 0001677044
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ACRV holding history

Acrivon Therapeutics, Inc. in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRV overview All 13F holders of ACRV Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of ACRV by Advisor Group Holdings, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−5,080−100.0%	Sold out	Holders
Q2 2024	5,080	$29.5K	<0.1%	00.0%	Unchanged	Holders
Q1 2024	5,080	$36.3K	<0.1%	+5,080	New	Holders